Related Experiment Video
Updated: Sep 15, 2025

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Rash and edema shortly after initial exposure to low dose cenobamate.
Christopher Saouda1, Yamane Makke1, Helen Edelberg1
1Department of Neurology, George Washington University, Washington, DC, USA.
Cenobamate (CNB), an antiseizure medication for focal epilepsy, can cause uncommon skin reactions. Two patients experienced facial and chest rash and edema after starting CNB, resolving upon discontinuation.
Area of Science:
- Neurology
- Dermatology
Background:
- Cenobamate (CNB) is an approved antiseizure medication (ASM) for treating focal epilepsy.
- Adverse effects like rash and edema are considered uncommon with CNB therapy.
Observation:
- Two patients with medically refractory epilepsy (MRE) were initiated on CNB at a low dose (12.5 mg/d).
- Both patients developed distinct chest and facial rash and edema shortly after the initial CNB dose.
Findings:
- Discontinuation of CNB led to the resolution of the observed rash and edema in both patients.
- Re-administration of CNB in one patient reproduced the adverse skin reactions, confirming a causal link.
Implications:
- This case report highlights the potential for cenobamate to induce uncommon dermatological adverse events, including rash and edema.
- Increased clinical awareness of these specific CNB reactions is crucial for timely diagnosis and management in patients with epilepsy.
Related Concept Videos
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Allergic Drug Reactions
Allergic Reactions
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Desensitization and Tachyphylaxis
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...

